ICP
EVH icon

Interchange Capital Partners’s Evolent Health EVH Stock Holding History

Interchange Capital Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-132
Closed -$2K – 499
2020
Q4 		$2K Buy
+132
New +$1.75K ﹤0.01% 1077

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Interchange Capital Partners's EVH Position: Q1 2021 in Review

Interchange Capital Partners sold out of Evolent Health (EVH) in Q1 2021, closing a stake of 132 shares — an estimated $2K sold.

Interchange Capital Partners first reported a position in EVH in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 168 funds tracked by Wall St. Rank hold EVH as of Q1 2021.

  • Interchange Capital Partners reported no remaining Evolent Health position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 132 Evolent Health shares in Q1 2021, an estimated $2K.
  • Interchange Capital Partners first reported a position in Evolent Health in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's Evolent Health position peaked at $2K in Q4 2020.
  • 168 funds tracked by Wall St. Rank held Evolent Health as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.